
To evaluate the association between pretreatment total lymphocyte counts (TLC) and survival outcomes in locally advanced cervical cancer (LACC) patients treated with definite concurrent chemoradiotherapy (CCRT). Fifty‐two patients had pretreatment TLC <1000 cells/mm3. The 5‐year DFS and OS rates were significantly higher in patients with pretreatment TLC >1000 cells/mm3 than their counterparts (67.7% vs 35.4% [P<0.0001] and 57.6% vs 25.7% [P<0.0001], respectively). In multivariate analysis, pretreatment TLC >1000 cells/mm3 was an independent predictor of DFS (HR, 0.39; 95% confidence interval [CI] 0.26‐0.59, P<0.001) and OS (HR, 0.59; 95% CI 0.42‐0.84, P=0.006). Therefore, Pretreatment TLC was associated with treatment response and survival outcome in patients with LACC treated with definite CCRT.
Like
Save
Share